Changes in immune parameters observed in this systematic review, such as increased levels of IL-6 and TNF-α or altered lymphocyte subsets, may play a significant role in the development of specific maternal and fetal complications associated with GDM. This evidence concerns the gene IL6 and gestational diabetes.